CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mylan Pharmaceuticals Inc. vs. Qualicaps Co., Ltd.

Explore the PTAB proceeding IPR2017-00203 filed by Mylan Pharmaceuticals Inc. on 2016-11-04. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2017-00203

Filing Date

2016-11-04

Accorded Filing Date

2016-11-04

Institution Decision Date

2017-05-16

Last Modified Date

2021-02-02

Proceeding Type

IPR

Termination Date

2017-12-19

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 09549205
Respondent Patent Number 6649180
Legal Expiration Date
2020-04-13 Expired (Term Ended)
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred
Respondent Tech Center TC 1700 - Chemical & Materials Engineering

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1700 - Chemical & Materials Engineering

Decisions Rendered

0 Total

Proceeding Status

Terminated-Settled

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 3 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (3 found):
U.S. Courts: 3
U.S. District Court 2016-04-01
2:16-cv-00323

Warner Chilcott (US), LLC v. Zydus Pharmaceuticals (USA) Inc.

Asserted Patent
Status: TXED
U.S. District Court 2015-11-09
2:15-cv-01740

Warner Chilcott (US), LLC v. Mylan Pharmaceuticals, Inc.

Asserted Patent
Status: TXED
U.S. District Court 2015-08-31
1:15-cv-00761

Warner Chilcott (US), LLC v. Teva Pharmaceuticals USA, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

145
62

Granting Patent Owners Motion to Expunge 37 C.F.R. sec 42.5 Paper

2017-12-22 FILING PARTY: BOARD
61

Patent Owner's Unopposed Motion to Expunge Confidential Information Paper

2017-12-20 FILING PARTY: PATENT OWN
60

Termination of the Proceedings 37 C.F.R. sec 42.72 Paper

2017-12-19 FILING PARTY: BOARD
57

JOINT MOTION TO TERMINATE UNDER 35 U.S.C. ΒΏΒΏ 317(a) Paper

2017-12-18 FILING PARTY: PETITIONER
58

Petitioner's Updated Exhibit List Paper

2017-12-18 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc